X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16) 16
humans (15) 15
middle aged (14) 14
aged (13) 13
female (13) 13
male (12) 12
mortality (11) 11
cardiac & cardiovascular systems (10) 10
adult (8) 8
aged, 80 and over (7) 7
denmark (7) 7
denmark - epidemiology (7) 7
risk factors (7) 7
abridged index medicus (6) 6
proportional hazards models (6) 6
registries (6) 6
beta-blockers (5) 5
events (5) 5
myocardial infarction - mortality (5) 5
acute myocardial-infarction (4) 4
care and treatment (4) 4
diabetes mellitus, type 2 - drug therapy (4) 4
experiment (4) 4
heart failure (4) 4
high energy physics - experiment (4) 4
kaplan-meier estimate (4) 4
myocardial infarction (4) 4
myocardial infarction - drug therapy (4) 4
particle physics (4) 4
peripheral vascular disease (4) 4
pharmacoepidemiology (4) 4
physics (4) 4
risk (4) 4
survival analysis (4) 4
treatment outcome (4) 4
acute myocardial infarction (3) 3
adrenergic beta-antagonists - therapeutic use (3) 3
anti-inflammatory agents, non-steroidal - therapeutic use (3) 3
cardiology (3) 3
cardiovascular diseases - epidemiology (3) 3
cardiovascular diseases - mortality (3) 3
cardiovascular events (3) 3
cohort studies (3) 3
cyclooxygenase-2 inhibitors (3) 3
heart attack (3) 3
heart-failure (3) 3
hospitalization (3) 3
hypoglycemic agents - therapeutic use (3) 3
incidence (3) 3
mellitus (3) 3
outcomes (3) 3
patient outcomes (3) 3
pharmacology & pharmacy (3) 3
physics - high energy physics - experiment (3) 3
population (3) 3
recurrence (3) 3
stroke - mortality (3) 3
time factors (3) 3
usage (3) 3
validity (3) 3
7000 gev-cms8000 gev-cms (2) 2
angiotensin-converting enzyme inhibitors - therapeutic use (2) 2
anti-inflammatory agents, non-steroidal - adverse effects (2) 2
bibliography (2) 2
biography (2) 2
blood-glucose control (2) 2
cardiovascular diseases - etiology (2) 2
cause of death (2) 2
celecoxib (2) 2
cern lab (2) 2
cern lhc coll (2) 2
clopidogrel (2) 2
comorbidity (2) 2
complications (2) 2
converting enzyme-inhibitors (2) 2
cross-over studies (2) 2
cyclo-oxygenase-2 inhibitors (2) 2
diabetes (2) 2
diabetes mellitus (2) 2
diabetes mellitus, type 2 - blood (2) 2
diabetes mellitus, type 2 - complications (2) 2
diabetes mellitus, type 2 - epidemiology (2) 2
diagnosis (2) 2
drug treatment (2) 2
drugs (2) 2
enzymes (2) 2
epidemiology (2) 2
experimental results (2) 2
glimepiride (2) 2
glucose (2) 2
glyburide (2) 2
guidelines (2) 2
hadron-hadron scattering (2) 2
health risk assessment (2) 2
heart attacks (2) 2
heart failure - drug therapy (2) 2
heart failure - mortality (2) 2
hep (2) 2
hormone replacement therapy (2) 2
hospital discharge (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (4) 4
UTL at Downsview - May be requested (3) 3
Art - Deshman (2) 2
Pontifical Inst. Mediaeval Studies - Library use only (2) 2
Institute for Christian Studies - Stacks (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation, ISSN 0009-7322, 04/2008, Volume 117, Issue 15, pp. 1945 - 1954
Background - Previous studies reveal major differences in the estimated cardiovascular risk in diabetes mellitus, including uncertainty about the risk in young... 
Stroke | Prognosis | Diabetes mellitus | Mortality | Cardiovascular diseases | Coronary disease | Epidemiology | REGISTER | CARDIAC & CARDIOVASCULAR SYSTEMS | GUIDELINES | FOLLOW-UP | diabetes mellitus | cardiovascular diseases | MELLITUS | prognosis | stroke | coronary disease | epidemiology | ALL-CAUSE | IMPACT | mortality | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | VALIDITY | ASSOCIATION | Diabetes Mellitus, Type 1 - epidemiology | Recurrence | Myocardial Infarction - epidemiology | Age Factors | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Male | Risk | Diabetes Mellitus, Type 1 - complications | Hypoglycemic Agents - classification | Diabetes Mellitus, Type 2 - epidemiology | Aged, 80 and over | Cardiovascular Diseases - mortality | Adult | Female | Registries | Stroke - mortality | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Comorbidity | Proportional Hazards Models | Forecasting | Diabetes Mellitus, Type 1 - drug therapy | Cardiovascular Agents - therapeutic use | Stroke - etiology | Survival Analysis | Denmark - epidemiology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - therapeutic use | Diabetics | Care and treatment | Demographic aspects | Patient outcomes | Outcome and process assessment (Health Care) | Comparative analysis | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 06/2006, Volume 113, Issue 25, pp. 2906 - 2913
Background-The selective cyclooxygenase-2 (COX-2) inhibitors and other nonselective nonsteroidal antiinflammatory drugs ( NSAIDs) have been associated with... 
Drugs | Myocardial infarction | Cyclooxygenase-2 inhibitors | Mortality | Nonsteroidal antiinflammatory drugs | RHEUMATOID-ARTHRITIS | POPULATION | CARDIAC & CARDIOVASCULAR SYSTEMS | drugs | CARDIOVASCULAR EVENTS | myocardial infarction | CONVERTING ENZYME-INHIBITORS | RANDOMIZED CONTROLLED-TRIAL | CELECOXIB | BLOOD-PRESSURE | nonsteroidal antiinflammatory drugs | mortality | CYCLO-OXYGENASE-2 INHIBITORS | ROFECOXIB | PERIPHERAL VASCULAR DISEASE | BETA-BLOCKERS | HEMATOLOGY | cyclooxygenase-2 inhibitors | Ibuprofen - therapeutic use | Multivariate Analysis | Recurrence | Sulfones - therapeutic use | Confidence Intervals | Myocardial Infarction - mortality | Pyrazoles - therapeutic use | Patient Readmission | Humans | Middle Aged | Sulfones - adverse effects | Male | Dose-Response Relationship, Drug | Cyclooxygenase 2 Inhibitors - adverse effects | Cyclooxygenase 2 Inhibitors - therapeutic use | Aged, 80 and over | Female | Registries | Retrospective Studies | Odds Ratio | Pyrazoles - adverse effects | Diclofenac - therapeutic use | Diclofenac - adverse effects | Risk Factors | Proportional Hazards Models | Celecoxib | Lactones - adverse effects | Lactones - therapeutic use | Cross-Over Studies | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Myocardial Infarction - drug therapy | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Denmark | Sulfonamides - adverse effects | Aged | Ibuprofen - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 08/2009, Volume 120, Issue 6, pp. 510 - 517
Journal Article
Circulation: Cardiovascular Quality and Outcomes, ISSN 1941-7713, 07/2010, Volume 3, Issue 4, pp. 395 - 405
Journal Article
Circulation, ISSN 0009-7322, 08/2007, Volume 116, Issue 7, pp. 737 - 744
Journal Article
Diabetes Research and Clinical Practice, ISSN 0168-8227, 2014, Volume 107, Issue 1, pp. 104 - 112
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2010, Volume 55, Issue 13, pp. 1300 - 1307
Journal Article
Journal Article